Category supply reports
The registration data for each therapeutic category Ogbogwu tracks — who holds the registrations, where the products are made, what was newly approved and what comes due for renewal. Every number is quoted from our August 2026 copy of the NAFDAC Greenbook and recomputed with each monthly register refresh.
Antibiotics
908 active registrations from 315 companies, across 15 molecules.
66 new in 12 months · 262 renewals due within a year
Read the report →Pain & Fever
720 active registrations from 299 companies, across 10 molecules.
80 new in 12 months · 118 renewals due within a year
Read the report →Antimalarials
424 active registrations from 222 companies, across 6 molecules.
67 new in 12 months · 53 renewals due within a year
Read the report →Hypertension
280 active registrations from 116 companies, across 8 molecules.
31 new in 12 months · 66 renewals due within a year
Read the report →Dermatology
275 active registrations from 114 companies, across 5 molecules.
22 new in 12 months · 29 renewals due within a year
Read the report →Vitamins & Supplements
182 active registrations from 88 companies, across 7 molecules.
12 new in 12 months · 34 renewals due within a year
Read the report →Digestive Health
181 active registrations from 114 companies, across 7 molecules.
11 new in 12 months · 50 renewals due within a year
Read the report →Diabetes
150 active registrations from 54 companies, across 10 molecules.
11 new in 12 months · 26 renewals due within a year
Read the report →Allergy
129 active registrations from 85 companies, across 5 molecules.
9 new in 12 months · 33 renewals due within a year
Read the report →Respiratory
116 active registrations from 82 companies, across 3 molecules.
7 new in 12 months · 33 renewals due within a year
Read the report →Eye & Ear Drops
93 active registrations from 62 companies, across 3 molecules.
9 new in 12 months · 24 renewals due within a year
Read the report →Antifungals
62 active registrations from 51 companies, across 2 molecules.
8 new in 12 months · 12 renewals due within a year
Read the report →Sexual Health
62 active registrations from 46 companies, across 2 molecules.
9 new in 12 months · 15 renewals due within a year
Read the report →Cholesterol
52 active registrations from 31 companies, across 3 molecules.
12 new in 12 months · 14 renewals due within a year
Read the report →Cough, Cold & Flu
41 active registrations from 28 companies, across 4 molecules.
3 new in 12 months · 8 renewals due within a year
Read the report →Antiparasitics
39 active registrations from 29 companies, across 3 molecules.
1 new in 12 months · 9 renewals due within a year
Read the report →Blood Thinners
38 active registrations from 33 companies, across 3 molecules.
5 new in 12 months · 6 renewals due within a year
Read the report →Epilepsy
27 active registrations from 21 companies, across 3 molecules.
4 new in 12 months · 2 renewals due within a year
Read the report →Reproductive Health
25 active registrations from 21 companies, across 2 molecules.
3 new in 12 months · 6 renewals due within a year
Read the report →Each report states its scope — the molecules it counts — because the register itself has no therapeutic grouping. Registration data is not market-share or sales data; for decisions that matter, confirm on the official Greenbook.